TrialFrontiers in immunology2023

Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer.

Chaoyuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.